St. Jude Medical (STJ) 80.88 $STJ
Global Automotive Hydro-mechanical Variable Transmission System Market 2016-2020 with Kinetics Drive Solutions & Bosch Rexroth St. Jude Medical Dominating
GlobeNewswire - Tue Jul 12, 5:28AM CDT
Research and Markets has announced the addition of the "Global Automotive Hydro-mechanical Variable Transmission System Market 2016-2020" report to their offering.
STJ: 80.88 (+0.21)
St Jude Medical Has Returned 49.2% Since SmarTrend Recommendation (STJ)
Comtex SmarTrend(R) - Mon Jul 11, 12:51PM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 5 months, St Jude Medical has returned 49.24% as of today's recent price of $80.86.
STJ: 80.88 (+0.21)
St. Jude Medical Continues to Expand its Heart Failure Portfolio in the U.S. to Provide Physicians Additional Options for Managing Patients Not Responding to Other Therapies
BusinessWire - Mon Jul 11, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced Food and Drug Administration (FDA) approval and the launch of SyncAV(TM) CRT software, designed to build upon the company's first-to-market MultiPoint(TM) Pacing technology and further optimize St. Jude Medical's comprehensive cardiac resynchronization therapy (CRT) portfolio. The SyncAV CRT software algorithm is designed to function independently or in conjunction with MultiPoint Pacing Technology to address and effectively treat heart failure patients, some of whom are not responsive to other pacing options.
STJ: 80.88 (+0.21)
Research and Markets - Global LVAD Market 2016-2020 with Abiomed, Berlin Heart, HeartWare International, Jarvik Heart & St. Jude Medical Dominating
PR Newswire Europe - Thu Jul 07, 12:10PM CDT
Research and Markets has announced the addition of the "Global LVAD Market 2016-2020" [http://www.researchandmarkets.com/research/s6lm9k/global_lvad] report to their offering.
STJ: 80.88 (+0.21)
Abbott Labs' Absorb Stent Gets Regulatory Approval in U.S.
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:58AM CDT
Abbott Laboratories (ABT) received a major boost when the FDA approved its bioresorbable heart stent, Absorb, for the treatment of coronary artery disease in the U.S.
ABT: 42.47 (+0.35), JNJ: 122.92 (-0.01), PFE: 36.24 (+0.09), STJ: 80.88 (+0.21)
Medical Device Consolidation Frenzy: Here's How to Play it
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:00AM CDT
The medical device majors struggling with their core businesses are often on the lookout for emerging therapies through acquisitions and alliances.
ABT: 42.47 (+0.35), JNJ: 122.92 (-0.01), ZBH: 125.46 (+0.38), LDRH: 36.98 (-0.02), MDT: 88.92 (+0.41), TMO: 154.38 (+2.04), STJ: 80.88 (+0.21), HTWR: 57.68 (+0.21), XRAY: 63.13 (-0.61), NUVA: 61.00 (-0.57), FEIC: 106.77 (-0.02)
What Investors are Making of These Medical Appliances and Equipment Stocks? - St. Jude Medical, ResMed, Steris, and Varian Medical Systems
PR Newswire - Thu Jul 07, 6:40AM CDT
Stock-Callers.com's focus this morning is on the Medical Appliances and Equipment industry, which can expect strong growth for the remainder of this year despite headwinds. We look at the featured companies for today and review their recent performances: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks and receive your complimentary notes at:
VAR: 86.26 (+0.46), STE: 69.38 (+0.29), RMD: 64.02 (-0.26), STJ: 80.88 (+0.21), MDSY: 1.51 (-0.04)
Uptrend Call Working As St Jude Medical Stock Rises 44.7% (STJ)
Comtex SmarTrend(R) - Fri Jul 01, 12:54PM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 4 months, St Jude Medical has returned 44.68% as of today's recent price of $78.39.
STJ: 80.88 (+0.21)
GNC Holdings' Overseas Prospects Robust Amid Market Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 4:35PM CDT
On Jun 30, 2016, we issued an updated research report on Pittsburgh, PA-based GNC Holdings, Inc. (GNC).
BSX: 23.64 (-0.13), ICUI: 115.22 (-0.52), GNC: 26.34 (+0.59), STJ: 80.88 (+0.21)
Medtronic (MDT) Focuses on Cardiac Management Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 9:00AM CDT
Following the release, shares of Medtronic gained 1.56% to reach $85.45 at the end of yesterday's trading session.
BSX: 23.64 (-0.13), ICUI: 115.22 (-0.52), MDT: 88.92 (+0.41), STJ: 80.88 (+0.21)
St. Jude Medical Announces Second Quarter 2016 Earnings Conference Call
BusinessWire - Tue Jun 28, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that it will report financial results for its second quarter of its fiscal year 2016 on Wednesday, July 20, 2016. A news release will be issued at approximately 6:15 a.m. CT and the company will hold its quarterly conference call to discuss the financial results at 7 a.m. CT (8 a.m. ET).
STJ: 80.88 (+0.21)
St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies
BusinessWire - Thu Jun 23, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced CE Mark approval and launch of SyncAV(TM) CRT software, designed to build upon the company's first-to-market MultiPoint(TM) Pacing technology and further optimize St. Jude Medical's comprehensive cardiac resynchronization therapy (CRT) portfolio. MultiPoint Pacing technology with the SyncAV CRT software algorithm is designed to address and effectively treat heart failure patients who are not responsive to other pacing options. The SyncAV technology, which automatically adjusts pacing based on real-time changes in a patient's cardiac condition, also provides physicians the opportunity to further improve treatment of patients who have responded positively to traditional CRT.
STJ: 80.88 (+0.21)
Walgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:26AM CDT
On Jun 22, 2016, we issued an updated research report on Walgreens Boots Alliance, Inc. (WBA).
WBA: 81.22 (-0.79), LMAT: 14.20 (+0.56), STJ: 80.88 (+0.21), NUVA: 61.00 (-0.57)
Lieberman Software Hosts Privilege Management Security Panel at Gartner Security & Risk Management Summit
Marketwired - Tue Jun 14, 4:30AM CDT
LOS ANGELES, CA--(Marketwired - Jun 14, 2016) - Lieberman Software Corporation today announced that it's leading a cyber security panel today at Gartner Security & Risk Management Summit 2016. Protecting Privilege as Cyber Defense - A Panel Discussion will be hosted by Jonathan Sander, Vice President of Product Strategy at Lieberman Software.
STJ: 80.88 (+0.21)
India Cardiovascular Devices Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, St. Jude Medical, Abbott Labs - Research and Markets
BusinessWire - Fri Jun 10, 12:10PM CDT
Research and Markets has announced the addition of the "India Cardiovascular Devices Market Outlook to 2021 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others" report to their offering.
ABT: 42.47 (+0.35), MDT: 88.92 (+0.41), STJ: 80.88 (+0.21)
43.9% Return Seen to Date on SmarTrend St Jude Medical Call (STJ)
Comtex SmarTrend(R) - Thu Jun 09, 12:23AM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 4 months, St Jude Medical has returned 43.89% as of today's recent price of $77.96.
STJ: 80.88 (+0.21)
Technical Pulse on Medical Appliances & Equipment Stocks -- St. Jude Medical, ResMed, Steris, and Varian Medical Systems
PR Newswire - Mon Jun 06, 8:00AM CDT
On Friday, June 03, 2016, the NASDAQ Composite ended the trading session at 4,942.52, down 0.58%; the Dow Jones Industrial Average lost 0.18% to finish at 17,807.06; and the S&P 500 closed at 2,099.13, down 0.29%. ActiveWallSt.com has initiated coverage on the following equities: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks by accessing their free trade alerts at:
VAR: 86.26 (+0.46), STE: 69.38 (+0.29), RMD: 64.02 (-0.26), STJ: 80.88 (+0.21), MDSY: 1.51 (-0.04)
St. Jude Medical CardioMEMS HF System is Now Guideline Directed Therapy for Heart Failure Patients in Europe
BusinessWire - Mon Jun 06, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its CardioMEMS(TM) HF System was added to the European Society of Cardiology (ESC) guidelines as a directed therapy management and monitoring tool for heart failure patients. The new 2016 ESC Clinical Practice Guidelines for the diagnosis and treatment of acute and chronic heart failure for the first time include pulmonary artery pressure monitoring with the CardioMEMS HF System.
STJ: 80.88 (+0.21)
Global Automotive Hydro-mechanical Variable Transmission System Market 2016-2020 with Kinetics Drive Solutions & Bosch Rexroth St. Jude Medical Dominating
GlobeNewswire - Tue Jul 12, 5:28AM CDT
Research and Markets has announced the addition of the "Global Automotive Hydro-mechanical Variable Transmission System Market 2016-2020" report to their offering.
STJ: 80.88 (+0.21)
St Jude Medical Has Returned 49.2% Since SmarTrend Recommendation (STJ)
Comtex SmarTrend(R) - Mon Jul 11, 12:51PM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 5 months, St Jude Medical has returned 49.24% as of today's recent price of $80.86.
STJ: 80.88 (+0.21)
St. Jude Medical Continues to Expand its Heart Failure Portfolio in the U.S. to Provide Physicians Additional Options for Managing Patients Not Responding to Other Therapies
BusinessWire - Mon Jul 11, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced Food and Drug Administration (FDA) approval and the launch of SyncAV(TM) CRT software, designed to build upon the company's first-to-market MultiPoint(TM) Pacing technology and further optimize St. Jude Medical's comprehensive cardiac resynchronization therapy (CRT) portfolio. The SyncAV CRT software algorithm is designed to function independently or in conjunction with MultiPoint Pacing Technology to address and effectively treat heart failure patients, some of whom are not responsive to other pacing options.
STJ: 80.88 (+0.21)
Research and Markets - Global LVAD Market 2016-2020 with Abiomed, Berlin Heart, HeartWare International, Jarvik Heart & St. Jude Medical Dominating
PR Newswire Europe - Thu Jul 07, 12:10PM CDT
Research and Markets has announced the addition of the "Global LVAD Market 2016-2020" [http://www.researchandmarkets.com/research/s6lm9k/global_lvad] report to their offering.
STJ: 80.88 (+0.21)
Abbott Labs' Absorb Stent Gets Regulatory Approval in U.S.
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:58AM CDT
Abbott Laboratories (ABT) received a major boost when the FDA approved its bioresorbable heart stent, Absorb, for the treatment of coronary artery disease in the U.S.
ABT: 42.47 (+0.35), JNJ: 122.92 (-0.01), PFE: 36.24 (+0.09), STJ: 80.88 (+0.21)
Medical Device Consolidation Frenzy: Here's How to Play it
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:00AM CDT
The medical device majors struggling with their core businesses are often on the lookout for emerging therapies through acquisitions and alliances.
ABT: 42.47 (+0.35), JNJ: 122.92 (-0.01), ZBH: 125.46 (+0.38), LDRH: 36.98 (-0.02), MDT: 88.92 (+0.41), TMO: 154.38 (+2.04), STJ: 80.88 (+0.21), HTWR: 57.68 (+0.21), XRAY: 63.13 (-0.61), NUVA: 61.00 (-0.57), FEIC: 106.77 (-0.02)
What Investors are Making of These Medical Appliances and Equipment Stocks? - St. Jude Medical, ResMed, Steris, and Varian Medical Systems
PR Newswire - Thu Jul 07, 6:40AM CDT
Stock-Callers.com's focus this morning is on the Medical Appliances and Equipment industry, which can expect strong growth for the remainder of this year despite headwinds. We look at the featured companies for today and review their recent performances: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks and receive your complimentary notes at:
VAR: 86.26 (+0.46), STE: 69.38 (+0.29), RMD: 64.02 (-0.26), STJ: 80.88 (+0.21), MDSY: 1.51 (-0.04)
Uptrend Call Working As St Jude Medical Stock Rises 44.7% (STJ)
Comtex SmarTrend(R) - Fri Jul 01, 12:54PM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 4 months, St Jude Medical has returned 44.68% as of today's recent price of $78.39.
STJ: 80.88 (+0.21)
GNC Holdings' Overseas Prospects Robust Amid Market Woes
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 4:35PM CDT
On Jun 30, 2016, we issued an updated research report on Pittsburgh, PA-based GNC Holdings, Inc. (GNC).
BSX: 23.64 (-0.13), ICUI: 115.22 (-0.52), GNC: 26.34 (+0.59), STJ: 80.88 (+0.21)
Medtronic (MDT) Focuses on Cardiac Management Portfolio
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 9:00AM CDT
Following the release, shares of Medtronic gained 1.56% to reach $85.45 at the end of yesterday's trading session.
BSX: 23.64 (-0.13), ICUI: 115.22 (-0.52), MDT: 88.92 (+0.41), STJ: 80.88 (+0.21)
St. Jude Medical Announces Second Quarter 2016 Earnings Conference Call
BusinessWire - Tue Jun 28, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that it will report financial results for its second quarter of its fiscal year 2016 on Wednesday, July 20, 2016. A news release will be issued at approximately 6:15 a.m. CT and the company will hold its quarterly conference call to discuss the financial results at 7 a.m. CT (8 a.m. ET).
STJ: 80.88 (+0.21)
St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies
BusinessWire - Thu Jun 23, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced CE Mark approval and launch of SyncAV(TM) CRT software, designed to build upon the company's first-to-market MultiPoint(TM) Pacing technology and further optimize St. Jude Medical's comprehensive cardiac resynchronization therapy (CRT) portfolio. MultiPoint Pacing technology with the SyncAV CRT software algorithm is designed to address and effectively treat heart failure patients who are not responsive to other pacing options. The SyncAV technology, which automatically adjusts pacing based on real-time changes in a patient's cardiac condition, also provides physicians the opportunity to further improve treatment of patients who have responded positively to traditional CRT.
STJ: 80.88 (+0.21)
Walgreen Boots Hopeful on Rite Aid Buyout amid Margin Woes
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:26AM CDT
On Jun 22, 2016, we issued an updated research report on Walgreens Boots Alliance, Inc. (WBA).
WBA: 81.22 (-0.79), LMAT: 14.20 (+0.56), STJ: 80.88 (+0.21), NUVA: 61.00 (-0.57)
Lieberman Software Hosts Privilege Management Security Panel at Gartner Security & Risk Management Summit
Marketwired - Tue Jun 14, 4:30AM CDT
LOS ANGELES, CA--(Marketwired - Jun 14, 2016) - Lieberman Software Corporation today announced that it's leading a cyber security panel today at Gartner Security & Risk Management Summit 2016. Protecting Privilege as Cyber Defense - A Panel Discussion will be hosted by Jonathan Sander, Vice President of Product Strategy at Lieberman Software.
STJ: 80.88 (+0.21)
India Cardiovascular Devices Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Medtronic, St. Jude Medical, Abbott Labs - Research and Markets
BusinessWire - Fri Jun 10, 12:10PM CDT
Research and Markets has announced the addition of the "India Cardiovascular Devices Market Outlook to 2021 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others" report to their offering.
ABT: 42.47 (+0.35), MDT: 88.92 (+0.41), STJ: 80.88 (+0.21)
43.9% Return Seen to Date on SmarTrend St Jude Medical Call (STJ)
Comtex SmarTrend(R) - Thu Jun 09, 12:23AM CDT
SmarTrend identified an Uptrend for St Jude Medical (NYSE:STJ) on February 22nd, 2016 at $54.18. In approximately 4 months, St Jude Medical has returned 43.89% as of today's recent price of $77.96.
STJ: 80.88 (+0.21)
Technical Pulse on Medical Appliances & Equipment Stocks -- St. Jude Medical, ResMed, Steris, and Varian Medical Systems
PR Newswire - Mon Jun 06, 8:00AM CDT
On Friday, June 03, 2016, the NASDAQ Composite ended the trading session at 4,942.52, down 0.58%; the Dow Jones Industrial Average lost 0.18% to finish at 17,807.06; and the S&P 500 closed at 2,099.13, down 0.29%. ActiveWallSt.com has initiated coverage on the following equities: St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE: RMD), Steris PLC (NYSE: STE), and Varian Medical Systems Inc. (NYSE: VAR). Learn more about these stocks by accessing their free trade alerts at:
VAR: 86.26 (+0.46), STE: 69.38 (+0.29), RMD: 64.02 (-0.26), STJ: 80.88 (+0.21), MDSY: 1.51 (-0.04)
St. Jude Medical CardioMEMS HF System is Now Guideline Directed Therapy for Heart Failure Patients in Europe
BusinessWire - Mon Jun 06, 7:00AM CDT
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its CardioMEMS(TM) HF System was added to the European Society of Cardiology (ESC) guidelines as a directed therapy management and monitoring tool for heart failure patients. The new 2016 ESC Clinical Practice Guidelines for the diagnosis and treatment of acute and chronic heart failure for the first time include pulmonary artery pressure monitoring with the CardioMEMS HF System.
STJ: 80.88 (+0.21)
